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Abstract
Aims To compare the psychometric properties of the
World Health Organization Quality of Life-BREF (WHO-
QOL-BREF) instrument and the St. George’s Respiratory
Questionnaire (SGRQ), and to examine the association
between pulmonary function and domains and items of
these questionnaires in patients with chronic obstructive
pulmonary disease (COPD).
Methods The WHOQOL-BREF and the SGRQ were
administered to 211 patients. The reliability and validity of,
and correlations among, the domain scores were examined.
Multiple regression analyses were performed to identify
which items were independently associated with subjects’
lung functions.
Results Both questionnaires showed good internal con-
sistency (a[0.8), except the SGRQ symptoms domain
(a = 0.66), minimal ceiling and ﬂoor effects, and good
item convergent and item discriminant validity. There were
moderate correlations between physical domain of the
WHOQOL-BREF and activity, impacts and total domains
of the SGRQ, and between psychological domain of the
WHOQOL-BREF and impacts and total domains of the
SGRQ. Eighteen items were signiﬁcantly associated with
lung function, particularly those items relating to mobility/
walking and activities of daily living (ADL).
Conclusion Both the WHOQOL-BREF and the SGRQ
showed comparable reliability and validity. Items related to
mobility/walking and ADL may be useful in clinical
screening for lung function impairment.
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Introduction
Chronic obstructive pulmonary disease (COPD) is a major
cause of chronic morbidity and mortality, and represents a
substantial economic and social burden throughout the
world. It is the ﬁfth leading cause of death worldwide and
its prevalence and mortality rate are projected to increase
in the coming decades [1]. As they age, patients with
COPD must cope with the gradual deterioration of their
pulmonary function and with increased psychological,
social, and ﬁnancial stress associated with such a pro-
gressive change [2]. Many studies have incorporated
health-related quality of life (HRQL) measurement in
assessing the impact and progression of chronic diseases,
including COPD [3–8].
A good number of questionnaires have been developed
and used to assess the HRQL of patients and the general
population, and they differ in numerous ways, such as
goals, contents, scaling methods and cultural factors.
Generic questionnaires, such as the Short-Form 36 (SF-36)
[9–11] and the World Health Organization Quality of Life-
BREF (WHOQOL-BREF) [12, 13], measure relatively
broad domains and can be used to conduct comparisons
across different diseases, ethnicities, and cultures. Disease-
speciﬁc questionnaires, such as the St. George’s Respira-
tory Questionnaire (SGRQ) [14, 15] and the Chronic
Respiratory Questionnaire [16], measure the extent to
which certain symptoms of a particular disease impact on
various HRQL domains.
The WHOQOL-BREF and the SGRQ are two well-
validated questionnaires that have been extensively applied
in the clinical assessment of HRQL of patients [17–20].
However, to our knowledge, there has been no comparative
evaluation of these two questionnaires in COPD patients.
By examining the comparative reliability and validity of
these two instruments, and determining the extent to which
each correlates with pulmonary function of COPD patients,
we will be able to have a better understanding of the
strengths and weaknesses of each questionnaire, and thus
provide information which will help in the interpretation of
these two instruments of patient reported outcomes [21]. In
addition, since lung function directly reﬂects the progres-
sive change of a COPD patient, but is not measured at each
clinical visit, it may be useful for a clinician to have a
quick screening tool for early detection of their changes
and prescription for such a test. Thus, we were also inter-
ested in whether certain items would be signiﬁcant
predictors for impairment of lung function and potentially
useful in daily clinical practice.
Methods
Study populations and data collection
Patients with a diagnosis of COPD according to the 2003
global initiative for chronic obstructive lung disease
(GOLD) [22–24] were enrolled in the study. According to
the World Health Organization GOLD, smoking is a major
cause of COPD [22]. In Taiwan, prevalence of smoking
(including ex-smokers) among males over 50 years is
approximately 54%, compared with only about 4% in
females in the same age group in 2001 [25]. There were
relatively few female patients with COPD compared with
males in the clinical setting. Thus, we focused our analysis
on male COPD patients. A total of 211 patients were
consecutively recruited from outpatient clinics of two
teaching hospitals and two local hospitals in central Taiwan
from January 1, 2003 to April 1, 2005. Those who had
cognitive problems and lung cancer were excluded. All
consented participants were interviewed in person by a
trained nurse in each of the four outpatient clinics.
HRQL was assessed by the WHOQOL-BREF Taiwan-
ese version [26] and the Chinese version of the St.
George’s respiratory questionnaire (SGRQ) [27, 28]. Data
about socio-demographic characteristics and medical his-
tory were also obtained. Lung function examinations were
performed on the same visit and included forced expiratory
volume in 1 s (FEV1), forced vital capacity (FVC), and
FEV1/FVC ratio from spirometry (JAEGER, MasterScreen
PFT). Patients were then divided into ﬁve groups based on
their lung function parameters as deﬁned by the 2003
GOLD guidelines: stage 0 (at risk), stage I (mild COPD),
stage II (moderate COPD), stage III (severe COPD), and
stage IV (very severe COPD) [23].
Measurement tools
The WHOQOL-BREF
The WHOQOL-BREF Taiwanese version is comprised of
two general items, 24 items universally adopted for the
WHOQOL-BREF to cover four domains (physical, psy-
chological, social, and environment), and two culturally-
speciﬁc items for use in Taiwan (‘‘Do you feel respected by
others?’’ and ‘‘Are you usually able to get the things you
like to eat?’’) [26]. Negatively-worded items are recoded,
so a higher score always indicates a better HRQL, ranging
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score according to the WHOQOL guidelines [29].
The SGRQ
A translated and validated version of the SGRQ for use in
Taiwan was utilized [27, 28]. The SGRQ is composed of 50
items measuring three domains: (1) symptoms—to assess
the frequency and severity of the patient’s symptoms; (2)
activity—to determine how a patient’s respiratory status
affects their daily activities; and (3) impacts—to investigate
the socio-functional and psychological impairment imposed
upon the patient by respiratory diseases. The response
options range from 2- to 5-point ordinal scales and each
question is weighted individually for scoring. The domain
score is expressed as a percentage of the weighted total of
all the questions; the numerator is the weighted score of the
patient in that domain, and the denominator is the highest
score that can be obtained in that domain, ranging from 0 to
100%. The total domain sums up all weighted items of the
above three domains, which reﬂects the overall health sit-
uation. Higher scores indicate poorer HRQL [30].
Statistical analysis
Known-groups validity
Patients’ HRQL scores were presented as means for each
disease stage. Analysis of variance was used to test whether
the domain scores in the two questionnaires could dis-
criminate among different disease stages. Simple regression
analysis was used to test whether there was a linear trend
between disease stages and the domain scores.
Reliability
The internal consistency reliability of each domain was
assessed by Cronbach’s coefﬁcient alpha. A value of 0.7 or
greater was considered to be acceptable [31, 32].
Floor and ceiling effects
The ﬂoor effect was shown as the percentage of subjects
with the lowest possible domain scores. The ceiling effect
was presented as the percentage of subjects with the
highest possible domain scores.
Item convergent validity and item discriminant validity
Item convergent validity and item discriminant validity
were assessed to evaluate the scale construct for each
questionnaire. Item convergent validity within each domain
was evaluated by correlating each item with its respective
scale (corrected for overlap). A corrected correlation
greater than 0.4 was considered to be appropriate [10]. Item
discriminant validity was assessed by comparing the cor-
relation of each item with its own domain (corrected for
overlap) with the correlation of each item with the other
domains in the same questionnaire. An item was consid-
ered to be valid when it correlated signiﬁcantly higher (two
standard errors or more) with its own domain than with
other domains in the same questionnaire [10].
Correlation analysis
A multitrait-multimethod correlation matrix (MTMM) [33,
34] was used to evaluate the relationships between the
domains of the WHOQOL-BREF and the SGRQ. More-
over, the domain scores of these two instruments were also
tested for correlations with the more objective pulmonary
functions (FEV1 percent predicted and FEV1/FVC ratio).
As a general guideline, correlations from 0.00 to 0.25
indicate little or no relationship, from 0.25 to 0.50 a fair
degree of relationship, from 0.50 to 0.75 a moderate to
good relationship, and above 0.75 a good to excellent
relationship [32]. For inter-domain, intra-instrument cor-
relations, we expected that the all domains within each of
the two instruments were moderately correlated with each
other, as our study subjects were homogenous male senior
citizens suffering from COPD. For inter-domain, inter-
instrument correlations, we hypothesized that: (1) the
physical domain of the WHOQOL-BREF would have
moderate to high correlations with the activity, impact and
total domains of the SGRQ; (2) the psychological domain
of the WHOQOL-BREF would have moderate to high
correlations with the impact and total domains of the
SGRQ; (3) the social domain of the WHOQOL-BREF
would have moderate to high correlations with the impact
and total domains of the SGRQ; and (4) the environmental
domain of the WHOQOL-BREF would have a fair corre-
lation with any domain of the SGRQ.
Items related to lung function impairment
We were interested in identifying whether certain items in
thetwoinstrumentswouldbeusefulpredictorsthatcanserve
asasentineltocliniciansforearlydetectionofprogressionof
disease and subsequent prescription of lung function test.
Two multiple regression models (one with FEV1 percent
predicted and the other one with FEV1/FVC ratio as the
dependent variable) were performed with each item sepa-
rately as an independent variable to assess its ability in
predicting a patient’s lung function. Both models were
adjustedforage,educationlevel,marital status andsmoking
status.Anitemwasconsideredtobeapotentialpredictorifit
was statistically signiﬁcant (P\0.01) in both models.
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Characteristics of subjects
A total of 211 male patients were enrolled and studied,
with age ranging from 46 to 88 years and an average of
70.4. Mean FEV1 percent predicted was 56.2% and the
mean FEV1/FVC ratio was 56%. About two-thirds of the
participants had elementary school education or below, 183
(87.1%) lived with a spouse, and about a quarter were still
current smokers. Most patients were in GOLD stage II or
III, as summarized in Table 1. Because this study was
designed and conducted during 2002–2005, we applied the
2003 GOLD criteria and therefore included patients with
stage 0 or at risk.
Scaling properties of the WHOQOL-BREF and the
SGRQ
Table 2 shows each of the mean domain scores decreased
for the WHOQOL-BREF and increased for the SGRQ (all
P\0.05 for both analysis from ANOVA and test for a
linear trend) at the later stages of COPD, indicating that
patients’ HRQL signiﬁcantly deteriorated as their COPD
became more severe. Both questionnaires had good internal
consistency (a[0.8), except the SGRQ symptoms domain
(a = 0.66). Neither questionnaire showed a marked ﬂoor
effect or ceiling effect (all domains were \ 7%). Table 2
also shows that both questionnaires had a high item dis-
criminant validity, but the success rates for the item
convergent validity for domains of the WHOQOL-BREF
seemed higher than those of the SGRQ.
Correlation analysis among HRQL domains and lung
functions
Table 3 summarizes the results of correlation analysis
between the WHOQOL-BREF and the SGRQ as well as
correlations between their individual domains and lung
function indicators. As expected, there were moderate to
high inter-domain, intra-instrument correlations within the
domains of each of the two instruments, except between
the domains of symptoms and activity of the SGRQ. For
inter-domain, inter-instrument analysis, all magnitudes of
correlations were as we expected, except that the correla-
tions between social domain of the WHOQOL-BREF and
domains of impacts and total of the SGRQ were fair. There
were fair correlations between both indicators of lung
function and the physical domain of the WHOQOL-BREF
as well as between lung function indicators and domains of
the activity, impacts and total of the SGRQ.
Selection of potential predicting items of lung function
impairment
Table 4 summarizes the signiﬁcant items in predicting both
major parameters of lung function (FEV1 percent predicted
and FEV1/FVC ratio), which were obtained from multiple
regression analyses with one HRQL item in each model
after the adjustments for age, education, marriage, and
smoking status. Three out of 7 items in the physical domain
from the WHOQOL-BREF, and 15 items out of the SGRQ
(1 in the 8-item symptoms domain, 7 in the 16-item activity
domain, and 7 in the 26-item impacts domain) were sig-
niﬁcantly associated with lung functions (P\0.01 for both
models). In the WHOQOL-BREF, there were three
potential items in physical domain, among them one item
related to mobility and one item related to activity of daily
living (ADL). Among the seven potential items in the
activity domain of the SGRQ, there were a set of ﬁve
hierarchical items related to mobility/walking; the other
two items were related to patient’s ADL.
Discussion
This study found that both the WHOQOL-BREF and the
SGRQ had good reliability and acceptable degrees of item
convergent and item discriminant validity for measuring
HRQL in patients with COPD. The Cronbach’s alpha coef-
ﬁcients ofbothinstruments were mostly greaterthan 0.8 and
Table 1 Demographic and clinical characteristics of the COPD
patients enrolled in this study (n = 211)
Variable
Age, mean years (SD) 70.4 (8.1)
Lung function, mean % (SD)
FEV1
a % predicted 56.2 (22.0)
FEV1/FVC
b ratio 56.0 (12.4)
Education, n (%)
Elementary school and below 142 (67.6)
Junior and senior high school 58 (27.6)
Junior college and above 10 (4.8)
Married and lives with spouse, n (%) 183 (87.1)
Current smokers, n (%) 58 (27.6)
Disease severity
c, n (%)
Stage 0: at risk 23 (10.9)
Stage I: mild 13 (6.2)
Stage II: moderate 74 (35.1)
Stage III: severe 84 (39.8)
Stage IV: very severe 17 (8.0)
a FEV1 Forced expiratory volume in 1 s
b FVC Forced vital capacity
c Classiﬁed according to 2003 GOLD criteria
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The alpha value (a = 0.66) of the SGRQ symptoms domain
was similar with two other validation studies [37, 39], but
lower than those of previous studies on COPD and other
diseases of the lungs [35, 36, 40]. Rutten-van Molken et al.
[36] reported alpha values of all SGRQ domains ranging
from 0.76 to 0.77 in 144 moderate to severe COPD patients,
while this study included patients with ‘‘at risk’’ and mild,
yielding a diversiﬁed coverage and wider range of different
levels of symptoms and therefore a lower reliability.
In the WHOQOL-BREF, the inter-domain, intra-instru-
ment correlation between physical and social domains
(r = 0.53) was the lowest, indicating social relationships
were usually not affected so much before the physical
condition severely deteriorated, as was also found in
another study conducted on HIV patients by Hsiung et al.
[38]. In the SGRQ, the correlations between symptoms and
activity (r = 0.46) and between symptoms and impacts
(r = 0.54) were the two lowest, which is consistent with
the ﬁndings in previous studies [41, 42]. This may be
Table 2 Scaling properties of domains and items of the two questionnaires (n = 211): the WHOQOL-BREF (World Health Organization
Quality of Life-Brief version) and the SGRQ (St. George’s Respiratory Questionnaire)
Stage (known groups validity) (%) at ﬂoor (%) at ceiling Item convergent
validity
Item discriminant
validity
At risk I II III IV P
a P
b a Success items
c/
total items (%)
Success items
d/
total items (%)
WHOQOL-BREF
Physical 15.2 13.8 12.9 12.3 9.8 ** ** 0.80 1.0 0.5 6/7 (85.7) 25/28 (89.3)
Psychological 15.4 11.9 12.3 12.5 10.7 ** ** 0.85 1.0 1.0 6/6 (100) 24/24 (100)
Social 15.9 11.8 13.0 12.7 11.4 ** ** 0.85 2.8 5.2 4/4 (100) 16/16 (100)
Environmental 16.4 13.7 14.6 14.3 13.5 ** ** 0.85 0 1.0 9/9 (100) 35/36 (97)
SGRQ
Symptoms 40.2 47.8 51.4 53.5 61.9 * ** 0.66 0 1.4 6/8 (75.0) 23/24 (95.8)
Activity 29.5 35.6 48.2 57.9 68.5 ** ** 0.90 2.4 6.2 15/16 (93.8) 45/48 (93.8)
Impacts 17.1 20.1 27.1 35.7 41.4 ** ** 0.90 0 5.2 19/26 (73.1) 71/78 (91.0)
Total 24.6 29.4 37.4 45.4 53.0 ** ** 0.94 0 0 – –
a *P\0.05, **P\0.01, based on one-way ANOVA
b **P\0.01, based on test for a linear trend
c In which correlation between an item and its own domain was -0.4
d In which correlation between an item and its own domain was signiﬁcantly greater than the item and other domains in the same questionnaire
Table 3 Correlations among domain scores of the WHOQOL-BREF and the SGRQ and lung functions (n = 211)
WHOQOL-BREF SGRQ
Physical Psycho. Social Environ. Symptoms Activity Impacts Total
WHOQOL-BREF
Physical 1
Psychological 0.71** 1
Social 0.53** 0.73** 1
Environmental 0.57** 0.72** 0.65** 1
SGRQ
Symptoms -0.39** -0.40** -0.42** -0.29** 1
Activity -0.59** -0.40** -0.35** -0.31** 0.46** 1
Impacts -0.69** -0.56** -0.43** -0.40** 0.54** 0.63** 1
Total -0.71** -0.56** -0.46** -0.41** 0.68** 0.85** 0.93** 1
Lung functions
FEV1% predicted 0.32** 0.17** 0.13 0.12 -0.19** -0.39** -0.29** -0.36**
FEV1/FVC 0.27** 0.20** 0.15* 0.16* -0.23** -0.30** -0.25** -0.30**
*P\0.05, **P\0.01, based on Student’s t test
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questions about respiratory symptoms (cough, sputum,
wheezing and so on), which is shown in the lower internal
consistency in this domain (a = 0.66). The fair inter-
domain, inter-instrument correlations between social and
environmental domains in the WHOQOL-BREF with all
domains in the SGRQ seemed to indicate that the former
has a broader coverage on these two issues. Similarly, the
fair correlations between symptoms domain of the SGRQ
and all domains in the WHOQOL-BREF indicated that the
symptoms were not appropriately reﬂected in any domain
of the latter.
Although all domains in the SGRQ and physical domain
in the WHOQOL-BREF showed a consistent deterioration
of HRQL scores associated with increased disease stage,
such a trend did not seem apparent in the psychological,
social, and environmental domains of the WHOQOL-
BREF. In other words, the WHOQOL scores in these three
domains dropped in stage I, recovered a little in stages II
and III, and become worse in stage IV. This ﬁnding sug-
gests that patients entering into stage I of COPD might
have experienced a period of psychological, social, and
environmental adjustments as they learned to cope with the
condition [43]. Thus, a timely care and emotional support
provided by clinicians and/or family members at this stage
may be very crucial to improve their HRQL, and can
proactively help these patients establish a more positive
outlook and healthy lifestyle.
The domains of activity, impact, and total of the SGRQ
correlated fairly with the lung function of patients with
COPD, as did the physical domain of the WHOQOL-
BREF. In general, the activity and total domains of the
SGRQ showed the highest correlation, as has been previ-
ously reported [3, 35, 37, 44, 45], but all the correlation
coefﬁcients were below 0.5. Instead, among the 18 poten-
tial items selected from multiple regression models, 9 were
Table 4 Items that are predictive of lung function impairment within the WHOQOL-BREF and the SGRQ in multiple regression analyses with
one HRQL item in each model after adjustment for age, education, marriage, and smoking status (n = 211)
Item Model I
FEV1% predicted
Model II
FEV1/FVC
P
a P
a
WHOQOL-BREF
Physical
Do you feel that physical pain prevents you from doing what you need to do 0.0006 0.003
How is your ability to get around
b \0.0001 \0.0001
Are you satisﬁed with your ability to perform routine daily activities
c 0.0003 0.0001
SGRQ
Symptoms (frequency of respiratory symptom)
Shortness of breath 0.0075 0.0076
Activity (activities that cause or are limited by breathlessness)
Walking around the home
b \0.0001 0.0033
Walking outside on the level
b \0.0001 0.0024
Walking up a ﬂight of stairs
b 0.0009 0.0071
Walking up hills
b 0.0056 0.0004
I walk more slowly than other people, or I stop for rests
b \0.0001 0.0032
Getting washed or dressed
c \0.0001 0.0019
Jobs such as housework take a long time, or I have to stop for rests
c \0.0001 0.0001
Impacts (aspects concerned with daily life, social functioning and psychological disturbances resulting from airways disease)
How would you describe your chest condition cause you problems \0.0001 0.0053
I get breathless when I talk 0.0014 0.0007
I have become frail or an invalid because of my chest \0.0001 0.0055
I cannot play sports or games 0.0002 0.0045
I cannot go out for entertainment or recreation \0.0001 0.0014
I cannot go out of the house to do the shopping 0.0002 0.0014
The extent to which your chest affects you doing things \0.0001 0.0018
a Items selected when P values were\0.01 from both models
b Related to mobility/walking
c Related to activity of daily living (ADL)
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were predictive of lung function impairment. In the
WHOQOL-BREF, the items ‘‘How is your ability to get
around?’’ and ‘‘Are you satisﬁed with your ability to per-
form routine daily activities?’’ are general measures of
mobility and ADL, respectively. In the SGRQ, there are
ﬁve items related to different cardiopulmonary load by
walking, from the lowest level of ‘‘Walking around the
home’’ to ‘‘Walking up hills’’ plus one item of comparing
with others, namely, ‘‘Walk more slowly than other peo-
ple’’. There are also two items which measure ADL limited
by breathlessness: ‘‘Getting washed and dressed’’ and
‘‘Jobs such as housework take a long time, or I have to stop
for rests.’’ These results corroborated clinical intuition that
cardiopulmonary impairment or breathlessness usually ﬁrst
appear as functional insufﬁciency in mobility/walking [4,
43] and/or in performing ADL [4, 46], which could be
detected by both the WHOQOL-BREF and the SGRQ,
while the latter seems more sensitive because of more
items and more focused in COPD.
Although the 7 items out of 26 in the impacts domain
also showed a signiﬁcant trend with both lung functions
(both P\0.01; Table 4), these items are more diversiﬁed,
not easily remembered, and thus less feasible in clinical
application. Thus, we had some reservation on recom-
mending any speciﬁc collected items from the impacts
domain of the SGRQ for clinical screening as a sentinel for
prescribing lung function test.
Some limitations of the present study should be men-
tioned. First, the patient population tested was relatively
small. Second, the patient population included only male
COPD patients and most patients were of stages II and III.
Thus, the generalization should be cautious. Third, the
patients in this study were outpatients. Hospitalized
patients were usually too sick to be interviewed or perform
lung function test. Therefore, our results cannot be gen-
eralized to the most severe patients. Finally, although use
of the SGRQ and/or the WHOQOL at the item levels were
generally not recommended by the developer, the items we
obtained in predicting lung function impairment may be
useful in daily practice as a screening tool for early
detection of deterioration of lung function in COPD
patients.
In conclusion, both questionnaires showed comparable
reliability and validity for patients with COPD. The
SGRQ had a higher discriminatory power in predicting
lung function impairment for COPD patients than the
WHOQOL-BREF, while the latter seemed more reﬂective
to the patient’s psychological and/or social adjustment.
Items related to mobility/walking and ADL may be useful
to clinicians as a quick screening tool for decision to
prescribe lung function test and detect the progression of
COPD.
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